Lorenzo Pradelli

23PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Microeconomic theoryFood properties (incl. characteristics and health benefits)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 17, 2026
Cost-effectiveness of the GAAD algorithm for hepatocellular carcinoma surveillance of patients with compensated cirrhosis: a model-based analysis using Italian real-world data.

Camilla Porta, Lorenzo Pradelli, Giovanni Cirotto

|Jan 23, 2026
Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic Data.

Mimma Rizzo, Gaetano Pezzicoli, Camilla Porta

|Apr 21, 2025
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy.

Stefano Luminari, Antonio Pinto, Benedetta Puccini

|Apr 16, 2025
Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy.

Luca Prosperini, Lorenzo Pradelli, Laura Santoni

|Apr 12, 2025
Parenteral Nutrition Containing Fish Oil for Hospitalized Non-Intensive Care Unit (ICU) Patients: A Systematic Review, Meta-Analysis, and Cost-Effectiveness Analysis.

Lorenzo Pradelli, Axel Rüdiger Heller, Stanislaw Klek

|Dec 21, 2024
Fish oil lipid emulsion compared with soybean oil lipid emulsion in pediatric patients with parenteral nutrition-associated cholestasis: A cost-effectiveness study.

Massimiliano Povero, Kathleen M Gura, Muralidhar H Premkumar

Pageof 4

Frequent Collaborators

6 joint publications

Stanislaw Klek

3 joint publications

Maurizio Muscaritoli

3 joint publications

Massimiliano Povero

2 joint publications

Alice Sabinot